Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Markers of Defective Membrane Remodelling in Scott-like Syndromes

This study has been terminated.
Sponsor:
Collaborators:
Louis Pasteur University, Strasbourg
Institut National de la Santé Et de la Recherche Médicale, France
Aventis, Génopôle d'Evry.
Information provided by (Responsible Party):
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT00617721
First received: February 5, 2008
Last updated: June 16, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given